University of Barcelona research

Researchers at the University of Barcelona have identified a network of nearly 20 genes that may increase susceptibility to depression, anxiety and personality traits such as irritability and neuroticism, offering new insight into why these conditions often occur together.

At the center of the network is RBFOX1, a gene that regulates the activity of numerous other genes involved in brain development and function. Rather than acting as a single “depression gene,” RBFOX1 appears to function as a master regulator, coordinating the expression of multiple genes linked to psychiatric vulnerability.

The University of Barcelona findings, published in Progress in Neuro-Psychopharmacology & Biological Psychiatry, suggest that alterations affecting RBFOX1 could influence several biological processes simultaneously, including neuronal development, communication between neurons and neurotransmission. According to the researchers, this may help explain why depression frequently coexists with anxiety, insomnia and other psychiatric conditions.

University of Barcelona research
University of Barcelona

The study identified 19 genes regulated by RBFOX1 that appear to play a role in depression and at least one related trait. Among the most significant were SP4, TCF4, PAX6 and CADM2, all of which have previously been implicated in psychiatric or neurological disorders. TCF4 has been associated with schizophrenia and insomnia, while CADM2 has been linked to addiction and other mental health conditions. SP4 and PAX6 have also shown altered activity in animal studies of stress.

To identify the network, the researchers combined data from genome-wide association studies (GWAS), predicted gene expression in brain tissue, molecular network analyses and studies of rare genetic disorders. By integrating these complementary sources of evidence, they were able to prioritize genes supported by multiple independent lines of research.

The work adds to growing evidence that depression is a highly polygenic disorder, arising from the combined effects of hundreds or thousands of genetic variants, each contributing only a small increase in risk. Rather than pointing to a single genetic cause, the study highlights how disruptions to key regulatory genes such as RBFOX1 may have widespread effects across interconnected biological pathways.

The findings could eventually support the development of more precise biomarkers for identifying people at higher risk of depression and related disorders, as well as treatments targeting shared molecular mechanisms. Such approaches may allow clinicians to better distinguish biological subtypes of depression and tailor therapies accordingly.

The researchers at the University of Barcelona cautioned, however, that the findings require validation in additional populations before they can be translated into clinical practice. They also said future work should examine potential differences between men and women, given the higher prevalence of depression among women, and include laboratory experiments to clarify how the identified genes influence brain function.

While the University of Barcelona research advances understanding of the biological architecture underlying depression and related psychiatric disorders, it does not suggest that any single gene determines whether an individual will develop depression. Genetic susceptibility is only one part of the picture, interacting with environmental factors such as stress, trauma and life experiences.

Similar Posts